We are live on ! Find out more
SCM

Superstring Capital Management Portfolio holdings

AUM $140M
1-Year Est. Return 323.19%
This Fund
S&P 500
This Quarter Est. Return
+49.53%
1 Year Est. Return
+323.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$140M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow %
76.62%
Top 10 Hldgs %
70.43%
Holding
30
New
30
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$11.9M
2
ETNB
89bio
ETNB
+$9.39M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$9.08M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$7.5M
5
IMVT icon
Immunovant
IMVT
+$7.49M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 96.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
26
Allogene Therapeutics
ALLO
$618M
$713K 0.51%
+222,112
New +$630K
INZY
27
DELISTED
Inozyme Pharma
INZY
$528K 0.38%
+123,944
New +$440K
FUSN
28
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$440K 0.31%
+45,801
New +$223K
SPRB
29
Spruce Biosciences
SPRB
$122M
$348K 0.25%
+1,584
New +$183K
LSB
30
DELISTED
LakeShore Biopharma
LSB
$166K 0.12%
+30,792
New +$177K
1
2

Similar funds

GIM
Guild Investment Management Los Angeles, California $140M AUM 28.67% 1-Year Est. Return
SLWM
Stone Loft Wealth Management West Chester, Pennsylvania $140M AUM
NWA
Northwest Wealth Advisors Bellingham, Washington $140M AUM
WCM
WealthTrak Capital Management Virginia Beach, Virginia $140M AUM 17% 1-Year Est. Return
JD6
J Digital 6 Chicago, Illinois $140M AUM
CPC
CFC Planning Company Cicero, Indiana $140M AUM 22.33% 1-Year Est. Return
CFG
Chapman Financial Group Kailua, Hawaii $140M AUM 15.83% 1-Year Est. Return
RC
Rexford Capital Bellaire, Texas $140M AUM 28.19% 1-Year Est. Return

Superstring Capital Management's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Superstring Capital Management, which disclosed 30 positions worth $140M. Its ten largest holdings account for 70% of the portfolio.

Its largest position is Immunogen Inc: 598,072 shares worth $17.7M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets.

  • Superstring Capital Management's largest Q4 2023 buy was Immunogen Inc: 598,072 shares worth $17.7M.
  • Superstring Capital Management's ten largest holdings make up 70% of its $140M portfolio in Q4 2023.
  • Superstring Capital Management disclosed 30 positions in Q4 2023, its first 13F filing on record.

Based on Superstring Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.